Consortium Explores Sequencing to Study Rare Serious Adverse Reactions to Drugs
October 19, 2010
Consortium Explores Sequencing to Study Rare Serious Adverse Reactions to Drugs
In order to more comprehensively analyze genetic variants associated with adverse reactions to drugs, the SAEC launched two pilot projects to explore exome sequencing earlier this year, and is currently organizing a third.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Researchers Pinpoint Mutations, Copy Number Changes in Lymphoma Subtypes
August 2, 2011 / GenomeWeb Daily News - Team IDs Recurrent NOTCH1 Mutations in CLL Exomes
June 13, 2011 / GenomeWeb Daily News - Rare Disease Gene Detected Using Exome Sequencing, Disease Network Approach
April 12, 2011 / GenomeWeb Daily News - Q&A: Peter Mac's Ian Campbell on Cancer Genomics, Next-Gen Technologies, and Research in Australia
May 14, 2013 / BioArray News - Studies Point to Key Deletion Behind Rare Blood Group
April 8, 2013 / GenomeWeb Daily News